Cargando…
Nanobiotechnology as a platform for the diagnosis of COVID-19: a review
A sensitive method for diagnosing coronavirus disease 2019 (COVID-19) is highly required to fight the current and future global health threats due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2). However, most of the current methods exhibited high false‐negative rates, resulting in p...
Autores principales: | Abdelhamid, Hani Nasser, Badr, Gamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988262/ http://dx.doi.org/10.1007/s41204-021-00109-0 |
Ejemplares similares
-
Detection, prevention and treatment of COVID‐19 and opportunities for nanobiotechnology
por: Bao, Qing, et al.
Publicado: (2022) -
Nanobiotechnology
por: Diniz, Susana N., et al.
Publicado: (2013) -
Therapeutic applications of nanobiotechnology
por: Dutt, Yogesh, et al.
Publicado: (2023) -
Nanobiotechnology in combating CoVid-19
por: Ganapathy, Dhanraj, et al.
Publicado: (2020) -
Application of Nanobiotechnology for Early Diagnosis of SARS-CoV-2 Infection in the COVID-19 Pandemic
por: Sheervalilou, Roghayeh, et al.
Publicado: (2021)